| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes
* New England Inflammation and Tissue Protection Institute, Northeastern University, Boston, MA;
Division of Immunology, Institute for Medical Science, Dokkyo University School of Medicine, Tochigi, Japan;
Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; and
Institute of Physiology and Center for Integrative Human Physiology (CIHP), University of Zurich, Zurich, Switzerland
To evaluate the role of hypoxia-inducible factor 1
(HIF-1) and its TCR activation-inducible short isoform I.1 in T cell functions, we genetically engineered unique mice with: 1) knockout of I.1 isoform of HIF-1; 2) T cell-targeted HIF-1 knockdown; and 3) chimeric mice with HIF-1 gene deletion in T and B lymphocytes. In all three types of mice, the HIF-1-deficient T lymphocytes, which were TCR-activated in vitro, produced more proinflammatory cytokines compared with HIF-1-expressing control T cells. Surprisingly, deletion of the I.1 isoform, which represents <30% of total HIF-1 mRNA in activated T cells, was sufficient to markedly enhance TCR-triggered cytokine secretion. These data suggest that HIF-1 not only plays a critical role in oxygen homeostasis but also may serve as a negative regulator of T cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Address correspondence and reprint requests to: Dr. Michail Sitkovsky, New England Inflammation and Tissue Protection Institute, Northeastern University, 360 Huntington Avenue, 113MU, Boston, MA 02115. E-mail address: m.sitkovsky{at}neu.edu
2 Abbreviations used in this paper: HIF-1, hypoxia-inducible factor 1; ES cells, embryonic stem cell.
This article has been cited by other articles:
|
|
 |
|
  M. Ramanathan, W. Luo, B. Csoka, G. Hasko, D. Lukashev, M. V. Sitkovsky, and S. J. Leibovich Differential regulation of HIF-1{alpha} isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists J. Leukoc. Biol., September 1, 2009; 86(3): 681 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hatfield, B. Belikoff, D. Lukashev, M. Sitkovsky, and A. Ohta The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells J. Leukoc. Biol., September 1, 2009; 86(3): 545 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ben-Shoshan, A. Afek, S. Maysel-Auslender, A. Barzelay, A. Rubinstein, G. Keren, and J. George HIF-1{alpha} Overexpression and Experimental Murine Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 665 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Wendler, M. Busovsky-McNeal, S. Ghatpande, A. Kalinowski, K. S. Russell, and S. A. Rivkees Embryonic caffeine exposure induces adverse effects in adulthood FASEB J, April 1, 2009; 23(4): 1272 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Noman, S. Buart, J. Van Pelt, C. Richon, M. Hasmim, N. Leleu, W. M. Suchorska, A. Jalil, Y. Lecluse, F. El Hage, et al. The Cooperative Induction of Hypoxia-Inducible Factor-1{alpha} and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis J. Immunol., March 15, 2009; 182(6): 3510 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. S. Brooks, G. P. Elvidge, L. Glenny, J. M. Gleadle, C. Liu, J. Ragoussis, T. G. Smith, N. P. Talbot, L. Winchester, P. H. Maxwell, et al. Variations within oxygen-regulated gene expression in humans J Appl Physiol, January 1, 2009; 106(1): 212 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Elia, P. Cappello, M. Puppo, T. Fraone, C. Vanni, A. Eva, T. Musso, F. Novelli, L. Varesio, and M. Giovarelli Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile J. Leukoc. Biol., December 1, 2008; 84(6): 1472 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Sitkovsky, J. Kjaergaard, D. Lukashev, and A. Ohta Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia Clin. Cancer Res., October 1, 2008; 14(19): 5947 - 5952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jantsch, D. Chakravortty, N. Turza, A. T. Prechtel, B. Buchholz, R. G. Gerlach, M. Volke, J. Glasner, C. Warnecke, M. S. Wiesener, et al. Hypoxia and Hypoxia-Inducible Factor-1{alpha} Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function J. Immunol., April 1, 2008; 180(7): 4697 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srinivasan, D. T. Bolick, D. Lukashev, C. Lappas, M. Sitkovsky, K. R. Lynch, and C. C. Hedrick Sphingosine-1-Phosphate Reduces CD4+ T-Cell Activation in Type 1 Diabetes Through Regulation of Hypoxia-Inducible Factor Short Isoform I.1 and CD69 Diabetes, February 1, 2008; 57(2): 484 - 493. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
